Skip to main content
Back
Watch Compare

Tevogen Bio Holdings Inc.

Data quality: 83%
Also listed as TVGNW Nasdaq
TVGN
Nasdaq Manufacturing Chemicals
$5.78
▼ $0.03 (-0.52%)
Mkt Cap: 24.07 M
Price
$5.78
Mkt Cap
24.07 M
Day Range
$5.65 — $6.11
52-Week Range
$4.14 — $75.50
Volume
22,152
Open $5.88
50D / 200D Avg
$10.36
44.20% below
50D / 200D Avg
$30.26
80.90% below

Quick Summary

Key Takeaways

Negative free cash flow of -12.39 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.31
Interest Coverage-133.63

Valuation

PE (TTM)
-0.92
Above sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -0.9 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % — -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -26.28 M
ROE N/A ROA -599.70%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -12.39 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.31
Interest Coverage -133.63 Asset Turnover N/A
Working Capital -4.62 M Tangible Book Value -7.82 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.92 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -51.49%
Market Cap 24.07 M Enterprise Value 24.07 M
Per Share
EPS (Diluted TTM) -8.08 Revenue / Share N/A
FCF / Share -2.98 OCF / Share -2.96
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 47.17%
SBC-Adj. FCF -29.50 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Revenue — — — — —
Net Income -26.28 M -13.73 M -67,325.0 -28,745.0 4.41 M
EPS (Diluted) -8.08 -0.07 — — —
Gross Profit — — — — —
Operating Income -26.14 M -53.56 M — — —
EBITDA — — — — —
R&D Expenses 11.11 M 31.03 M — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense -195,618.0 184,037.0 256,031.0 — —
Income Tax 4,750.0 — — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2021 FY2022
Total Assets 4.38 M 3.46 M 17.04 M 352.85 M 357.14 M
Total Liabilities 12.62 M 10.14 M 17.73 M 15.18 M 15.06 M
Shareholders' Equity -8.23 M -6.67 M -17.38 M -14.23 M -14.78 M
Total Debt — — 0.0 — —
Cash & Equivalents 0.0 0.0 — 344,581.0 129,186.0
Current Assets 1.54 M 2.36 M 355,836.0 791,191.0 274,356.0
Current Liabilities 7.07 M 9.04 M 3.00 M 59,375.0 350,454.0